tiprankstipranks
Trending News
More News >

Robert Barrow Insider Profile

4 Followers
Robert Barrow, CEO, Director at Definium Therapeutics, holds 1.10M shares in Definium Therapeutics (Ticker: DFTX).
tipranks
Robert Barrow

Robert Barrow
Definium Therapeutics (DFTX)
CEO, Director

Not Ranked
Robert Barrow has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$19M
100.00%
A breakdown of Robert Barrow's holdings

Insider Roles

Definium Therapeutics
(DFTX)
CEO, Director
Roles that Robert Barrow holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Robert Barrow

Robert Barrow's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Definium Therapeutics
Feb 05, 2026
CEO, Director
Uninformative Buy
$18.97M
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 20, 2024
Informative Buy
$6.21K
1,000
$6.21
Mar 13, 2025
Uninformative Buy
$0.00
350,000
$0.00
Feb 05, 2026
Uninformative Buy
$0.00
320,000
$0.00
Jun 25, 2024
Uninformative Sell
$113.06K
15,659
$7.22
Sep 25, 2024
Uninformative Sell
$118.23K
19,771
$5.98
List of latest transactions for each holding click on a transaction to see Robert Barrow's performance on stock

Robert Barrow insider profile FAQ

What is the percentage of profitable transactions made by Robert Barrow?
The percentage of profitable transactions made by Robert Barrow is ―.
    What is the average return per transaction made by Robert Barrow?
    The average return per transaction made by Robert Barrow is ―.
      What stocks does Robert Barrow hold?
      Robert Barrow holds: DFTX stocks.
        What was Robert Barrow’s latest transaction?
        Robert Barrow latest transaction was an Uninformative Buy of ―.
          What was Robert Barrow's most profitable transaction?
          Robert Barrow’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Robert Barrow's role in Definium Therapeutics?
            Robert Barrow's role in Definium Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.